SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF PHARMACOLOGICAL TREATMENTS AND SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

被引：0
|
作者：
Spoorendonk, J. A. [1 ]
Sahbaz Gulser, S. [1 ]
Arca, E. [1 ]
Hurst, M. [2 ]
Zema, C. [3 ]
Contente, M. [2 ]
Krause, T. [2 ]
机构：
[1] OPEN Hlth, Rotterdam, Netherlands
[2] Bristol Myers Squibb, Uxbridge, Middx, England
[3] Bristol Myers Squibb, Lawrenceville, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MSR97
引用
收藏
页码：S368 / S368
页数：1
相关论文
共 50 条
  • [31] Lifetime Costs of Septal Reduction Therapies are Substantially Lower Compared to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy
    Daaboul, Yazan
    Rowin, Ethan
    Maron, Martin
    Kimmelstiel, Carey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B144 - B144
  • [32] SEX DIFFERENCES IN PATIENT SELECTION AND OUTCOMES OF SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN THE UNITED STATES
    Sreenivasan, Jayakumar
    Hooda, Urvashi
    Kaur, Simrat
    Sharma, Sachit
    Aronow, Wilbert S.
    Cooper, Howard A.
    Naidu, Srihari
    Panza, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 949 - 949
  • [33] Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy
    Lawin, D.
    Lawrenz, T.
    Radke, K.
    Stellbrink, C.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1759 - 1759
  • [34] A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy
    Menezes Junior, Antonio da Silva
    de Oliveira, Ana Ligia Valeriano
    Maia, Thais Aratak
    Botelho, Silvia Marcal
    CURRENT CARDIOLOGY REVIEWS, 2023, 19 (04) : 84 - 95
  • [35] Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients
    Lakkis, N
    Plana, JC
    Nagueh, S
    Killip, D
    Roberts, R
    Spencer, WH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (05): : 583 - +
  • [36] Current therapies for hypertrophic cardiomyopathy: a systematic review and meta-analysis of the literature
    Bayonas-Ruiz, Adrian
    Munoz-Franco, Francisca Maria
    Sabater-Molina, Maria
    Oliva-Sandoval, Maria Jose
    Gimeno, Juan R.
    Bonacasa, Barbara
    ESC HEART FAILURE, 2023, 10 (01): : 8 - 23
  • [37] PROGNOSTIC FACTORS AND SURROGATE ENDPOINTS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A SYSTEMATIC LITERATURE REVIEW
    Krause, T.
    Fleming, A.
    Hurst, M.
    Zema, C.
    Costello, J.
    Hawe, E.
    Ling, C.
    VALUE IN HEALTH, 2023, 26 (12) : S36 - S36
  • [38] ECONOMIC AND HUMANISTIC BURDEN IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - A SYSTEMATIC LITERATURE REVIEW
    Spoorendonk, J. A.
    Gulser, Sahbaz S.
    Arca, E.
    Hurst, M.
    Zema, C.
    Contente, M.
    Krause, T.
    VALUE IN HEALTH, 2022, 25 (12) : S374 - S374
  • [39] Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy
    Maurizi, N.
    Chiriatti, C.
    Fumagalli, C.
    Targetti, M.
    Passantino, S.
    Arretini, A.
    Tomberli, A.
    Baldini, K.
    Coppini, R.
    Marchionni, N.
    Cecchi, F.
    Olivotto, I.
    EUROPEAN HEART JOURNAL, 2018, 39 : 726 - 726
  • [40] SAFETY OF ALCOHOL SEPTAL ABLATION FOR SEPTAL REDUCTION PRIOR TO TRANSCATHETER MITRAL VALVE REPLACEMENT COMPARED TO OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Elhadi, Mohamed
    Guerrero, Mayra E.
    Rihal, Charanjit S.
    Eleid, Mackram F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 583 - 583
12345